Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine pharmacokinetics and subjective effects of Nicachet versus Nicorette gum and nasal spray
2010-024445-78Phase 2Active
- Sponsor
- Magle Group
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of nicotine in nicotine dependence (3 arms), sponsored by Magle Group. Primary endpoints: Maximum plasma concentration of nicotine and Time to maximum plasma concentration. Started Jan 2011; status: active.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2010-024445-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024445-78.